期刊文献+

高能超声聚焦刀联合动脉灌注化疗治疗中晚期胰腺癌的疗效观察 被引量:1

Clinical study of thermotherapy of HIFU in combination with intra - arterial infusion chemotherapy in treatment of advanced pancreatic cancer
原文传递
导出
摘要 目的观察高能超声聚焦刀(HIFU)联合动脉灌注化疗(健择+氟尿嘧啶)治疗中晚期胰腺癌的疗效。方法43例晚期胰腺癌患者随机分成两组:A组(23例)HIFU联合动脉动脉灌注化疗;B组(20例)单纯动脉灌注化疗。结果A组有效率60.9%,B组为35.0%;A组临床受益率73.9%,B组45%,两组比较差异有统计学意义(P〈0.05)。结论HIFU联合动脉灌注化疗方案治疗中晚期胰腺癌有更好疗效。 Objective To observe the effect of therapy of HIFU with intra - arterial infusion chemotherapy ( Gemcitabine and Fluorouracil) in the treatment of advanced pancreatic cancer. Methods The data of fourtythree patients with advanced pancreatic cancer Were randomly divided into group A ( HIFU + intra-arterial infusion chemotherapy) and group B ( intra-arterial infusion chemotherapy only). Results The effective rate in group A was 60.9% and 35.0% in group B. The clinical beneficial rate were 73.9% and 45.0% in group A and B respectively. There was significant difference between the two groups ( P 〈 0.05 ). Conclusions Therapy of HIFU with intra-arterial infusion chemotherapy is more effective in the treatment of the advanced pancreatic cancer respctively.
出处 《中国实用医刊》 2009年第8期36-37,共2页 Chinese Journal of Practical Medicine
关键词 高能超声聚焦刀 动脉灌注化疗 胰腺癌 High intensive focused ultrasound Intra-arterial infusion chemotherapy Pancreatic cancer
  • 相关文献

同被引文献31

  • 1陈平,宋俊彪,陈苏蓉,吴菁,孙慧琛.健择联合化疗合并高能聚焦超声刀治疗晚期胰腺癌疗效观察[J].中外医疗,2008,27(22):55-56. 被引量:2
  • 2谢德荣,陈岱佳,滕虹,林显敢,陈积圣,姚波,陈继跃,郑伟华.HIFU联用双氟他滨治疗晚期胰腺癌的初步临床研究[J].岭南现代临床外科,2001,1(4):226-228. 被引量:5
  • 3高远,冯军,王庆才.高能聚焦超声“刀”合并GP方案治疗晚期胰腺癌的疗效观察[J].苏州大学学报(医学版),2006,26(3):428-430. 被引量:9
  • 4曾庆东,吕丽红,张秀国,吕斌,高学军,公伟,李占元.高强度聚焦超声联合健择治疗晚期胰腺癌的临床研究[J].中华肝胆外科杂志,2006,12(11):748-750. 被引量:12
  • 5Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12): 2893-2897.
  • 6陈平, 孙燕, 周际昌, 主编. 肿瘤内科手册. 第3版. 北京: 人民卫生出版社, 1996: 30-34.
  • 7Leslie T, Kennedy J, Illing R, et al. High-intensity focused ultrasound ablation of liver tumors: can radiological assessment predict the histological response? British Journal of Radiology, 2008, 81: 564-571.
  • 8Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first- line therapy for patients with advanced pancreatic cancer: a randomized trial. J Clin Oncol, 1997, 15(6): 2403-2413.
  • 9Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org.
  • 10Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol, 2011, 64 (4): 401-406.

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部